高级检索
当前位置: 首页 > 详情页

Effects of exercise interventions on negative emotions, cognitive performance and drug craving in methamphetamine addiction

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ SSCI

机构: [1]Yunnan Univ, Sch Med, Kunming, Yunnan, Peoples R China [2]Yunnan Univ, Yunnan Technol Innovat Ctr Drug Addict Med, Kunming, Peoples R China [3]First Peoples Hosp Yunnan Prov, Dept Gen Surg, Kunming, Yunnan, Peoples R China [4]Dept Rehabil Educ & Correct, Drug Rehabil Adm Yunnan Prov, Kunming, Peoples R China [5]Kunming Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Kunming 650032, Yunnan, Peoples R China [6]Kunming Med Univ, Dept Ultrasound, Affiliated Hosp 1, Kunming, Peoples R China
出处:
ISSN:

关键词: methamphetamine use disorder physical exercise depression anxiety cognition drug craving

摘要:
Introduction: Methamphetamine is currently one of the most commonly used addictive substances with strong addiction and a high relapse rate. This systematic review aims to examine the effectiveness of physical activity in improving negative emotions, cognitive impairment, and drug craving in people with methamphetamine use disorder (MUD). Methods: A total of 17 studies out of 133 found from Embase and PubMed were identified, reporting results from 1836 participants from MUD populations. Original research using clearly described physical activity as interventions and reporting quantifiable outcomes of negative mood, cognitive function and drug craving level in people with MUD were eligible for inclusion. We included prospective studies, randomized controlled trials, or intervention studies, focusing on the neurological effects of physical activity on MUD. Results: Taken together, the available clinical evidence showed that physical activity-based interventions may be effective in managing MUD-related withdrawal symptoms. Discussion: Physical exercise may improve drug rehabilitation efficiency by improving negative emotions, cognitive behaviors, and drug cravings. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42024530359.

基金:

基金编号: 202305AK340001 202105AF150040 202202AS070077 202201AY070001-079 202201AU070227 2023J0011

语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2024]版:
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 精神病学
JCR分区:
出版当年[2023]版:
Q2 PSYCHIATRY
最新[2023]版:
Q2 PSYCHIATRY

影响因子: 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者:
第一作者机构: [1]Yunnan Univ, Sch Med, Kunming, Yunnan, Peoples R China [2]Yunnan Univ, Yunnan Technol Innovat Ctr Drug Addict Med, Kunming, Peoples R China
通讯作者:
通讯机构: [1]Yunnan Univ, Sch Med, Kunming, Yunnan, Peoples R China [2]Yunnan Univ, Yunnan Technol Innovat Ctr Drug Addict Med, Kunming, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82490 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号